Analysts’ Viewpoint on Vitamin D Testing Scenario
Vitamin D testing market is anticipated to grow at a steady pace during the forecast period owing to a rise in prevalence of vitamin D deficiency across the globe. 25-hydroxy D vitamin test is the most commonly performed test for the estimation of vitamin D levels in the serum plasma owing to the ease of identification of this molecule in the sample. North America dominated the global market, while Asia Pacific offers significant opportunity in the near future. Rise in number of patients suffering from vitamin D deficiency is boosting the demand for vitamin D testing and consequently, driving the market for vitamin D testing. Furthermore, significant product launches and strategic partnerships are notable strategies employed by key players to enhance their market presence. This is anticipated to fuel the global market. For instance, in 2019, Thorne launched five new at-home health tests, including vitamin D test, heart health, weight management, testosterone test, and menopause test.
Rise in awareness about the consequences of nutritional deficiencies, increase in the geriatric population, and rise in cases of chronic illnesses in both young and old populations have driven the global market revenue in the last few years. Vitamin D is one of the vital nutrients required by the human body for good health, cell growth, and stronger teeth. Based on the source, it is classified into two types - Vitamin D2, which is manmade and added to food, and Vitamin D3, which is synthesized in the human skin and can also be found in animal-based food. The incidence of vitamin D deficiency is increasing due to minimizing exposure to sunlight, low intake of vitamin D, poor absorption of food, and changes in lifestyles. Furthermore, the introduction of at-home testing kits and intravenous administration for quick results, combined with a rise in expenditure in the healthcare industry in various developing countries are expected to drive the vitamin D testing market size. The ability of vitamin D testing to identify bone malformations, bone softness, and weakness is also expected to increase the demand for testing, which is expected to have a positive impact on the market.
According to the National Center for Biotechnology Information (NCBI), Vitamin D deficiency is a global public health issue. Approximately one billion people worldwide have vitamin D deficiency, while 50% of the population has vitamin D insufficiency. The prevalence of patients with vitamin D deficiency is highest in the elderly, obese patients, nursing home residents, and hospitalized patients.
In the U.S., around 50% to 60% of nursing home residents and hospitalized patients had vitamin D deficiency. Vitamin D deficiency is known to be common in northern Europe, majorly in women with pigmented skin. The deficiency is reported to be three times more common in winter months as compared to that in other months in the U.K.
In the U.S., 47% of African-American infants and 56% of Caucasian infants have vitamin D deficiency, while over 90% of infants in Iran, Turkey, and India have vitamin D deficiency. In the adult population, 35% of adults in the U.S. are vitamin D deficient, while over 80% of adults in India and Bangladesh are Vitamin D deficient. In the U.S., 61% of the geriatric population is vitamin D deficient, whereas 90% in Turkey, 96% in India, and 67% in Iran were vitamin D deficient.
The rise in the prevalence of vitamin D and an increase in focus on its importance contribute to the rise in screening for vitamin D serum levels, thereby boosting the vitamin D testing business.
According to data published by the United Nations Department of Economics and Social Affairs, the geriatric population is expected to double to nearly 2.1 billion by 2050. The geriatric population is prone to deficiency of vitamin D. Chronic diseases affecting skin integrity such as peripheral vascular diseases (arterial insufficiency & venous hypertension) and diabetes is becoming increasingly common with the rise in the geriatric population. Frequent consequences include skin breakdown with ulcers and chronic wound formation. An increase in the geriatric population is likely to triple or quintuple the demand for medical services and trigger the growth of non-communicable diseases (heart, cancer, and diabetes), which account for about 87% of the health issues faced by the aged population in low, middle, and high-income countries. This situation also needs surgical interventions, consequently driving the global market for vitamin D testing. An increase in the geriatric population and a rise in vitamin D deficiency among this population is likely to boost the vitamin D testing market.
The 25-hydroxy vitamin D segment dominated the market and accounted for a notable market share in 2021. The segment is anticipated to expand at a high CAGR during the forecast period. This segment is expected to remain dominant during the forecast period, both in terms of revenues and market share.
Expansion of the segment can be attributed to an increase in the number of tests being performed globally, ease of identification, and estimation of 25-hydroxy D vitamin levels in the plasma serum owing to its longer half-life, even though it is present in smaller volumes. Furthermore, its ability to identify a range of bone disorders owing to the lack of recommended levels of vitamin D propels the segment.
The ELISA segment dominated the market and held a prominent share of the global market in 2021. The growth of the segment is attributed to the rapid automation of systems due to an increase in vitamin D tests. ELISA is a completely automated technique for vitamin D tests.
Vitamin D deficiency (VDD) is a common health issue in women during the early stage of pregnancy. Various clinical trials using ELISA have been carried out to measure the concentrations of 25-hydroxy vitamin D. It has been proven that women usually suffer from vitamin D deficiency during early pregnancy. Thus, stakeholders in the vitamin D testing landscape need to innovate and develop preventive techniques and ways of early detection of VDD during early pregnancy.
North America held a major share of the global market for vitamin D testing, in terms of revenue, in 2021. The region is projected to dominate the global market during the forecast period. The rise in the prevalence of vitamin D deficiency, the increase in prescriptions of vitamin D blood tests, the surge in the aging population, and the rise in the prevalence of vitamin D deficiency among the adult population boost the market in North America.
Europe is anticipated to be the second-largest market in terms of share and revenue during the forecast period. Vitamin D deficiency is a public health issue in Germany. It is significantly prevalent in the adult as well as the younger population. Moreover, various studies conducted in Germany indicate that the average intake of vitamin D does not meet the recommended daily intake levels. These factors increase the number of vitamin D blood tests performed in the country; consequently, fueling the market.
The vitamin D testing market in the Asia Pacific is expected to expand at a notable CAGR of 6.5% during the forecast period. Growth of the market in the region is attributed to an increase in the geriatric population, a rise in the prevalence of vitamin D deficiency, changing reimbursement scenario for these tests, and an increase in the focus of market players on strengthening their presence in emerging economies.
Key manufacturers operating in the global vitamin D testing business are gaining a competitive edge in the market by emphasizing mergers and tie-ups. Presently, the market is highly competitive, as a large number of companies are aiming to capitalize on the expansion of the market. The global vitamin D testing market is fragmented, with the presence of a large number of players. These include Bio-Rad Laboratories, Inc., Abbott Laboratories, F. Hoffmann-La Roche AG, Thermo Fisher Scientific, DiaSys Diagnostic Systems GmbH, DiaSorin, bioMérieux, Siemens AG, Quest Diagnostics, Danaher Corporation, and OmegaQuant.
Each of these players has been profiled in the vitamin D testing industry report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
|
Attribute |
Detail |
|
Market Size Value in 2021 |
US$ 605.3 Mn |
|
Market Forecast Value in 2031 |
More than US$ 1.06 Bn |
|
Growth Rate (CAGR) for 2022-2031 |
5.8% |
|
Forecast Period |
2022–2031 |
|
Historical Data Available for |
2017–2020 |
|
Quantitative Units |
US$ Mn/Bn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
The global market for vitamin D testing was valued at US$ 605.3 Mn in 2021
The global vitamin D testing market is projected to reach more than US$ 1.06 Bn by 2031
The global market is anticipated to expand at a CAGR of 5.8% from 2022 to 2031
The vitamin D deficiency epidemic is driving the global market for vitamin D testing.
Bio-Rad Laboratories, Inc., Abbott Laboratories, F. Hoffmann-La Roche AG, Thermo Fisher Scientific, DiaSys Diagnostic Systems GmbH, DiaSorin, bioMérieux, Siemens AG, Quest Diagnostics, and Danaher Corporation.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Vitamin D Testing Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Vitamin D Testing Market Analysis and Forecast, 2017 - 2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key Industry Developments
5.2. Vitamin D Deficiency Prevalence
5.3. Healthcare Industry Overview
5.4. Vitamin D Tests – Product Life Cycle
5.5. Covid 19 Impact Analysis
6. Global Vitamin D Testing Market Analysis and Forecast, by Test Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Test Type, 2017 - 2031
6.3.1. 25-Hydroxy D Vitamin
6.3.2. 1,25- Dihydroxy D Vitamin
6.4. Market Attractiveness, by Test Type
7. Global Vitamin D Testing Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by End-user, 2017 - 2031
7.3.1. Hospitals
7.3.2. Diagnostic Laboratories
7.3.3. Home-care
7.3.4. Point-of-care
7.3.5. Others
7.4. Market Attractiveness, by End-user
8. Global Vitamin D Testing Market Analysis and Forecast, by Technique
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Technique, 2017 - 2031
8.3.1. Radioimmunoassay
8.3.2. ELISA
8.3.3. HPLC
8.3.4. LC-MS
8.3.5. Others
8.4. Market Attractiveness, by Technique
9. Global Vitamin D Testing Market Analysis and Forecast, by Patient Type
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by Patient Type, 2017 - 2031
9.3.1. Adult
9.3.2. Pediatric
9.4. Market Attractiveness, by Patient Type
10. Global Vitamin D Testing Market Analysis and Forecast, by Indication
10.1. Introduction & Definition
10.2. Key Findings / Developments
10.3. Market Value Forecast, by Indication, 2017 - 2031
10.3.1. Osteoporosis
10.3.2. Rickets
10.3.3. Thyroid disorders
10.3.4. Malabsorption
10.3.5. Vitamin D Deficiency
10.3.6. Others
10.4. Market Attractiveness, by Indication
11. Global Vitamin D Testing Market Analysis and Forecast, by Region
11.1. Key Findings
11.2. Market Value Forecast, by Region
11.2.1. North America
11.2.2. Europe
11.2.3. Asia Pacific
11.2.4. Latin America
11.2.5. Middle East & Africa
11.3. Market Attractiveness, by Country/Region
12. North America Vitamin D Testing Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Test Type, 2017 - 2031
12.2.1. 25-Hydroxy D Vitamin
12.2.2. 1,25- Dihydroxy D Vitamin
12.3. Market Value Forecast, by End-user, 2017 - 2031
12.3.1. Hospitals
12.3.2. Diagnostic Laboratories
12.3.3. Home-care
12.3.4. Point-of-care
12.3.5. Others
12.4. Market Value Forecast, by Technique, 2017 - 2031
12.4.1. Radioimmunoassay
12.4.2. ELISA
12.4.3. HPLC
12.4.4. LC-MS
12.4.5. Others
12.5. Market Value Forecast, by Patient Type, 2017 - 2031
12.5.1. Adult
12.5.2. Pediatric
12.6. Market Value Forecast, by Indication, 2017 - 2031
12.6.1. Osteoporosis
12.6.2. Rickets
12.6.3. Thyroid disorders
12.6.4. Malabsorption
12.6.5. Vitamin D Deficiency
12.6.6. Others
12.7. Market Value Forecast, by Country, 2017 - 2031
12.7.1. U.S.
12.7.2. Canada
12.8. Market Attractiveness Analysis
12.8.1. By Test Type
12.8.2. By End-user
12.8.3. By Technique
12.8.4. By Patient Type
12.8.5. By Indication
12.8.6. By Country
13. Europe Vitamin D Testing Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Test Type, 2017 - 2031
13.2.1. 25-Hydroxy D Vitamin
13.2.2. 1,25- Dihydroxy D Vitamin
13.3. Market Value Forecast, by End-user, 2017 - 2031
13.3.1. Hospitals
13.3.2. Diagnostic Laboratories
13.3.3. Home-care
13.3.4. Point-of-care
13.3.5. Others
13.4. Market Value Forecast, by Technique, 2017 - 2031
13.4.1. Radioimmunoassay
13.4.2. ELISA
13.4.3. HPLC
13.4.4. LC-MS
13.4.5. Others
13.5. Market Value Forecast, by Patient Type, 2017 - 2031
13.5.1. Adult
13.5.2. Pediatric
13.6. Market Value Forecast, by Indication, 2017 - 2031
13.6.1. Osteoporosis
13.6.2. Rickets
13.6.3. Thyroid disorders
13.6.4. Malabsorption
13.6.5. Vitamin D Deficiency
13.6.6. Others
13.7. Market Value Forecast, by Country/Sub-region, 2017 - 2031
13.7.1. Germany
13.7.2. U.K.
13.7.3. France
13.7.4. Spain
13.7.5. Italy
13.7.6. Rest of Europe
13.8. Market Attractiveness Analysis
13.8.1. By Test Type
13.8.2. By End-user
13.8.3. By Technique
13.8.4. By Patient Type
13.8.5. By Indication
13.8.6. By Country/Sub-region
14. Asia Pacific Vitamin D Testing Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Test Type, 2017 - 2031
14.2.1. 25-Hydroxy D Vitamin
14.2.2. 1,25- Dihydroxy D Vitamin
14.3. Market Value Forecast, by End-user, 2017 - 2031
14.3.1. Hospitals
14.3.2. Diagnostic Laboratories
14.3.3. Home-care
14.3.4. Point-of-care
14.3.5. Others
14.4. Market Value Forecast, by Technique, 2017 - 2031
14.4.1. Radioimmunoassay
14.4.2. ELISA
14.4.3. HPLC
14.4.4. LC-MS
14.4.5. Others
14.5. Market Value Forecast, by Patient Type, 2017 - 2031
14.5.1. Adult
14.5.2. Pediatric
14.6. Market Value Forecast, by Indication, 2017 - 2031
14.6.1. Osteoporosis
14.6.2. Rickets
14.6.3. Thyroid disorders
14.6.4. Malabsorption
14.6.5. Vitamin D Deficiency
14.6.6. Others
14.7. Market Value Forecast, by Country/Sub-region, 2017 - 2031
14.7.1. China
14.7.2. Japan
14.7.3. India
14.7.4. Australia & New Zealand
14.7.5. Rest of Asia Pacific
14.8. Market Attractiveness Analysis
14.8.1. By Test Type
14.8.2. By End-user
14.8.3. By Technique
14.8.4. By Patient Type
14.8.5. By Indication
14.8.6. By Country/Sub-region
15. Latin America Vitamin D Testing Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Test Type, 2017 - 2031
15.2.1. 25-Hydroxy D Vitamin
15.2.2. 1,25- Dihydroxy D Vitamin
15.3. Market Value Forecast, by End-user, 2017 - 2031
15.3.1. Hospitals
15.3.2. Diagnostic Laboratories
15.3.3. Home-care
15.3.4. Point-of-care
15.3.5. Others
15.4. Market Value Forecast, by Technique, 2017 - 2031
15.4.1. Radioimmunoassay
15.4.2. ELISA
15.4.3. HPLC
15.4.4. LC-MS
15.4.5. Others
15.5. Market Value Forecast, by Patient Type, 2017 - 2031
15.5.1. Adult
15.5.2. Pediatric
15.6. Market Value Forecast, by Indication, 2017 - 2031
15.6.1. Osteoporosis
15.6.2. Rickets
15.6.3. Thyroid disorders
15.6.4. Malabsorption
15.6.5. Vitamin D Deficiency
15.6.6. Others
15.7. Market Value Forecast, by Country/Sub-region, 2017 - 2031
15.7.1. Brazil
15.7.2. Mexico
15.7.3. Rest of Latin America
15.8. Market Attractiveness Analysis
15.8.1. By Test Type
15.8.2. By End-user
15.8.3. By Technique
15.8.4. By Patient Type
15.8.5. By Indication
15.8.6. By Country/Sub-region
16. Middle East & Africa Vitamin D Testing Market Analysis and Forecast
16.1. Introduction
16.1.1. Key Findings
16.2. Market Value Forecast, by Test Type, 2017 - 2031
16.2.1. 25-Hydroxy D Vitamin
16.2.2. 1,25- Dihydroxy D Vitamin
16.3. Market Value Forecast, by End-user, 2017 - 2031
16.3.1. Hospitals
16.3.2. Diagnostic Laboratories
16.3.3. Home-care
16.3.4. Point-of-care
16.3.5. Others
16.4. Market Value Forecast, by Technique, 2017 - 2031
16.4.1. Radioimmunoassay
16.4.2. ELISA
16.4.3. HPLC
16.4.4. LC-MS
16.4.5. Others
16.5. Market Value Forecast, by Patient Type, 2017 - 2031
16.5.1. Adult
16.5.2. Pediatric
16.6. Market Value Forecast, by Indication, 2017 - 2031
16.6.1. Osteoporosis
16.6.2. Rickets
16.6.3. Thyroid disorders
16.6.4. Malabsorption
16.6.5. Vitamin D Deficiency
16.6.6. Others
16.7. Market Value Forecast, by Country/Sub-region, 2017 - 2031
16.7.1. GCC Countries
16.7.2. South Africa
16.7.3. Rest of Middle East & Africa
16.8. Market Attractiveness Analysis
16.8.1. By Test Type
16.8.2. By End-user
16.8.3. By Technique
16.8.4. By Patient Type
16.8.5. By Indication
16.8.6. By Country/Sub-region
17. Competition Landscape
17.1. Market Player – Competition Matrix (By Tier and Size of companies)
17.2. Market Share Analysis, by Company (2021)
17.3. Company Profiles
17.3.1. DiaSorin S.p.A.
17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.1.2. Financial Analysis
17.3.1.3. Growth Strategies
17.3.1.4. SWOT Analysis
17.3.2. DiaSys Diagnostic Systems GmbH
17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.2.2. Financial Analysis
17.3.2.3. Growth Strategies
17.3.2.4. SWOT Analysis
17.3.3. bioMérieux SA
17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.3.2. Financial Analysis
17.3.3.3. Growth Strategies
17.3.3.4. SWOT Analysis
17.3.4. Bio-Rad Laboratories
17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.4.2. Financial Analysis
17.3.4.3. Growth Strategies
17.3.4.4. SWOT Analysis
17.3.5. Abbott Laboratories
17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.5.2. Financial Analysis
17.3.5.3. Growth Strategies
17.3.5.4. SWOT Analysis
17.3.6. Siemens Healthineers
17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.6.2. Financial Analysis
17.3.6.3. Growth Strategies
17.3.6.4. SWOT Analysis
17.3.7. F. Hoffmann-La Roche Ltd
17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.7.2. Financial Analysis
17.3.7.3. Growth Strategies
17.3.7.4. SWOT Analysis
17.3.8. Thermo Fisher Scientific, Inc.
17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.8.2. Financial Analysis
17.3.8.3. Growth Strategies
17.3.8.4. SWOT Analysis
17.3.9. Quest Diagnostics Incorporated
17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.9.2. Financial Analysis
17.3.9.3. Growth Strategies
17.3.9.4. SWOT Analysis
17.3.10. Danaher Corporation
17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.10.2. Financial Analysis
17.3.10.3. Growth Strategies
17.3.10.4. SWOT Analysis
List of Tables
Table 01: Global Vitamin D Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031
Table 02: Global Vitamin D Testing Market Value (US$ Mn) Forecast, by Technique, 2017–2031
Table 03: Global Vitamin D Testing Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 04: Global Vitamin D Testing Market Value (US$ Mn) Forecast, by Patient Type, 2017–2031
Table 05: Global Vitamin D Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 06: Global Vitamin D Testing Market Size (US$ Mn) Forecast, by Region, 2017–2031
Table 07: North America Vitamin D Testing Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 08: North America Vitamin D Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031
Table 09: North America Vitamin D Testing Market Value (US$ Mn) Forecast, by Technique, 2017–2031
Table 10: North America Vitamin D Testing Market Value (US$ Mn) Forecast, by Patient Type, 2017–2031
Table 11: North America Vitamin D Testing Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 12: North America Vitamin D Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: Europe Vitamin D Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Europe Vitamin D Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031
Table 15: Europe Vitamin D Testing Market Value (US$ Mn) Forecast, by Technique, 2017–2031
Table 16: Europe Vitamin D Testing Market Value (US$ Mn) Forecast, by Patient Type, 2017–2031
Table 17: Europe Vitamin D Testing Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 18: Europe Vitamin D Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 19: Asia Pacific Vitamin D Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 20: Asia Pacific Vitamin D Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031
Table 21: Asia Pacific Vitamin D Testing Market Value (US$ Mn) Forecast, by Technique, 2017–2031
Table 22: Asia Pacific Vitamin D Testing Market Value (US$ Mn) Forecast, by Patient Type, 2017–2031
Table 23: Asia Pacific Vitamin D Testing Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 24: Asia Pacific Vitamin D Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 25: Latin America Vitamin D Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 26: Latin America Vitamin D Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031
Table 27: Latin America Vitamin D Testing Market Value (US$ Mn) Forecast, by Technique, 2017–2031
Table 28: Latin America Vitamin D Testing Market Value (US$ Mn) Forecast, by Patient Type, 2017–2031
Table 29: Latin America Vitamin D Testing Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 30: Latin America Vitamin D Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 31: Middle East & Africa Vitamin D Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 32: Middle East & Africa Vitamin D Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031
Table 33: Middle East & Africa Vitamin D Testing Market Value (US$ Mn) Forecast, by Technique, 2017–2031
Table 34: Middle East & Africa Vitamin D Testing Market Value (US$ Mn) Forecast, by Patient Type, 2017–2031
Table 35: Middle East & Africa Vitamin D Testing Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 36: Middle East & Africa Vitamin D Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Vitamin D Testing Market Snapshot
Figure 02: Global Vitamin D Testing Market Value (US$ Mn) and Distribution (%), by Region, 2021 and 2031
Figure 03: Global Vitamin D Testing Market Value (US$ Mn) Forecast, 2017–2031
Figure 04: Global Vitamin D Testing Market Value Share (%), by Test Type, 2021
Figure 05: Global Vitamin D Testing Market Value Share (%), by Technique, 2021
Figure 06: Global Vitamin D Testing Market Value Share (%), by Indication, 2021
Figure 07: Global Vitamin D Testing Market Value Share (%), by Patient Type, 2021
Figure 08: Global Vitamin D Testing Market Value Share (%), by End-user, 2021
Figure 09: Global Vitamin D Testing Market Value Share (%), by Region, 2021
Figure 10: Vitamin D Tests - Product Life Cycle
Figure 11: Vitamin D Testing Market - Key Industry Developments
Figure 12: Vitamin D Deficiency - Prevalence
Figure 13: Global Vitamin D Testing Market Value Share Analysis, by Test Type, 2021 and 2027
Figure 14: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by 25-Hydroxy D Vitamin, 2017–2031
Figure 15: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by 1,25-ihydroxy D Vitamin, 2017–2031
Figure 16: Global Vitamin D Testing Market Attractiveness, by Test Type, 2022‒2031
Figure 17: Key Trends - Global Vitamin D Testing Market, by Test Type
Figure 18: Global Vitamin D Testing Market Value Share Analysis, by Technique, 2021 and 2027
Figure 19: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Radioimmunoassay, 2017–2031
Figure 20: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by ELISA, 2017–2031
Figure 21: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by HPLC, 2017–2031
Figure 22: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by LC-MS, 2017–2031
Figure 23: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017–2031
Figure 24: Global Vitamin D Testing Market Attractiveness, by Technique, 2022‒2031
Figure 25: Key Trends - Global Vitamin D Testing Market, by Technique
Figure 26: Global Vitamin D Testing Market Value Share Analysis, by Indication, 2021 and 2031
Figure 27: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Osteoporosis, 2017–2031
Figure 28: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Rickets, 2017–2031
Figure 29: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Thyroid
Disorders, 2017–2031
Figure 30: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Malabsorption, 2017–2031
Figure 31: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Vitamin D Deficiency, 2017–2031
Figure 32: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017–2031
Figure 33: Global Vitamin D Testing Market Attractiveness, by Indication, 2022‒2031
Figure 34: Key Trends - Global Vitamin D Testing Market, by Indication
Figure 35: Global Vitamin D Testing Market Value Share Analysis, by Patient Type, 2021 and 2031
Figure 36: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Adult, 2017–2031
Figure 37: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Pediatric, 2017–2031
Figure 38: Global Vitamin D Testing Market Attractiveness, by Patient Type, 2022‒2031
Figure 39: Key Trends - Global Vitamin D Testing Market, by Patient Type
Figure 40: Global Vitamin D Testing Market Value Share Analysis, by End-user, 2021 and 2031
Figure 41: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospitals, 2017–2031
Figure 42: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Diagnostic Laboratories, 2017–2031
Figure 43: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Home Care, 2017–2031
Figure 44: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Point-of-care, 2017–2031
Figure 45: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017–2031
Figure 46: Global Vitamin D Testing Market Attractiveness, by End-user, 2022‒2031
Figure 47: Key Trends - Global Vitamin D Testing Market, by End-user
Figure 48: Vitamin D Testing Market: Regional Outlook
Figure 49: Global Vitamin D Testing Market Value (US$ Mn) Forecast, 2017–2031
Figure 50: Global Vitamin D Testing Market Value Share Analysis, by Region, 2021 and 2031
Figure 51: Global Vitamin D Testing Market Attractiveness, by Region, 2022-2031
Figure 52: North America Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2031
Figure 53: North America Vitamin D Testing Market Attractiveness Analysis, by Country, 2022–2031
Figure 54: North America Vitamin D Testing Market Value Share Analysis, by Country, 2021 and 2031
Figure 55: North America Vitamin D Testing Market Value Share Analysis, by Test Type, 2021 and 2031
Figure 56: North America Vitamin D Testing Market Value Share Analysis, by Technique, 2021 and 2031
Figure 57: North America Vitamin D Testing Market Value Share Analysis, by Patient Type, 2021 and 2031
Figure 58: North America Vitamin D Testing Market Value Share Analysis, by Indication, 2021 and 2031
Figure 59: North America Vitamin D Testing Market Value Share Analysis, by End-user, 2021 and 2031
Figure 60: North America Vitamin D Testing Market Attractiveness, by Test Type, 2022‒2031
Figure 61: North America Vitamin D Testing Market Attractiveness, by Technique, 2022‒2031
Figure 62: North America Vitamin D Testing Market Attractiveness, by Patient Type, 2022‒2031
Figure 63: North America Vitamin D Testing Market Attractiveness, by Indication, 2022‒2031
Figure 64: North America Vitamin D Testing Market Attractiveness, by End-user, 2022‒2031
Figure 65: Europe Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2031
Figure 66: Europe Vitamin D Testing Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 67: Europe Vitamin D Testing Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 68: Europe Vitamin D Testing Market Value Share Analysis, by Test Type, 2021 and 2031
Figure 69: Europe Vitamin D Testing Market Value Share Analysis, by Technique, 2021 and 2031
Figure 70: Europe Vitamin D Testing Market Value Share Analysis, by Patient Type, 2021 and 2031
Figure 71: Europe Vitamin D Testing Market Value Share Analysis, by Indication, 2021 and 2031
Figure 72: Europe Vitamin D Testing Market Value Share Analysis, by End-user, 2021 and 2031
Figure 73: Europe Vitamin D Testing Market Attractiveness, by Test Type, 2022‒2031
Figure 74: Europe Vitamin D Testing Market Attractiveness, by Technique, 2022‒2031
Figure 75: Europe Vitamin D Testing Market Attractiveness, by Patient Type, 2022‒2031
Figure 76: Europe Vitamin D Testing Market Attractiveness, by Indication, 2022‒2031
Figure 77: Europe Vitamin D Testing Market Attractiveness, by End-user, 2022‒2031
Figure 78: Asia Pacific Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2031
Figure 79: Asia Pacific Vitamin D Testing Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 80: Asia Pacific Vitamin D Testing Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 81: Asia Pacific Vitamin D Testing Market Value Share Analysis, by Test Type, 2021 and 2031
Figure 82: Asia Pacific Vitamin D Testing Market Value Share Analysis, by Technique, 2021 and 2031
Figure 83: Asia Pacific Vitamin D Testing Market Value Share Analysis, by Patient Type, 2021 and 2031
Figure 84: Asia Pacific Vitamin D Testing Market Value Share Analysis, by Indication, 2021 and 2031
Figure 85: Asia Pacific Vitamin D Testing Market Value Share Analysis, by End-user, 2021 and 2031
Figure 86: Asia Pacific Vitamin D Testing Market Attractiveness, by Test Type, 2022‒2031
Figure 87: Asia Pacific Vitamin D Testing Market Attractiveness, by Technique, 2022‒2031
Figure 88: Asia Pacific Vitamin D Testing Market Attractiveness, by Patient Type, 2022‒2031
Figure 89: Asia Pacific Vitamin D Testing Market Attractiveness, by Indication, 2022‒2031
Figure 90: Asia Pacific Vitamin D Testing Market Attractiveness, by End-user, 2022‒2031
Figure 91: Latin America Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2031
Figure 92: Latin America Vitamin D Testing Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 93: Latin America Vitamin D Testing Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 94: Latin America Vitamin D Testing Market Value Share Analysis, by Test Type, 2021 and 2031
Figure 95: Latin America Vitamin D Testing Market Value Share Analysis, by Technique, 2021 and 2031
Figure 96: Latin America Vitamin D Testing Market Value Share Analysis, by Patient Type, 2021 and 2031
Figure 97: Latin America Vitamin D Testing Market Value Share Analysis, by Indication, 2021 and 2031
Figure 98: Latin America Vitamin D Testing Market Value Share Analysis, by End-user, 2021 and 2031
Figure 99: Latin America Vitamin D Testing Market Attractiveness, by Test Type, 2022‒2031
Figure 100: Latin America Vitamin D Testing Market Attractiveness, by Technique, 2022‒2031
Figure 101: Latin America Vitamin D Testing Market Attractiveness, by Patient Type, 2022‒2031
Figure 102: Latin America Vitamin D Testing Market Attractiveness, by Indication, 2022‒2031
Figure 103: Latin America Vitamin D Testing Market Attractiveness, by End-user, 2022‒2031
Figure 104: Middle East & Africa Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2031
Figure 105: Middle East & Africa Vitamin D Testing Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 106: Middle East & Africa Vitamin D Testing Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 107: Middle East & Africa Vitamin D Testing Market Value Share Analysis, by Test Type, 2021 and 2031
Figure 108: Middle East & Africa Vitamin D Testing Market Value Share Analysis, by Technique, 2021 and 2031
Figure 109: Middle East & Africa Vitamin D Testing Market Value Share Analysis, by Patient Type, 2021 and 2031
Figure 110: Middle East & Africa Vitamin D Testing Market Value Share Analysis, by Indication, 2021 and 2031
Figure 111: Middle East & Africa Vitamin D Testing Market Value Share Analysis, by End-user, 2021 and 2031
Figure 112: Middle East & Africa Vitamin D Testing Market Attractiveness, by Test Type, 2022‒2031
Figure 113: Middle East & Africa Vitamin D Testing Market Attractiveness, by Technique, 2022‒2031
Figure 114: Middle East & Africa Vitamin D Testing Market Attractiveness, by Patient Type, 2022‒2031
Figure 115: Middle East & Africa Vitamin D Testing Market Attractiveness, by Indication, 2022‒2031
Figure 116: Middle East & Africa Vitamin D Testing Market Attractiveness, by End-user, 2022‒2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Vitamin D Testing Market
